| pubmed-article:15289365 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C0011065 | lld:lifeskim |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C0039231 | lld:lifeskim |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
| pubmed-article:15289365 | lifeskim:mentions | umls-concept:C0439810 | lld:lifeskim |
| pubmed-article:15289365 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:15289365 | pubmed:dateCreated | 2004-8-17 | lld:pubmed |
| pubmed-article:15289365 | pubmed:abstractText | Stratifiers of sudden and total mortality risk are needed to optimally target preventive therapies in patients with coronary artery disease and impaired ventricular function. We assessed the prognostic significance of ECG markers of conduction abnormalities and left ventricular hypertrophy in the Multicenter Unsustained Tachycardia Trial (MUSTT). | lld:pubmed |
| pubmed-article:15289365 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15289365 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15289365 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15289365 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15289365 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15289365 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:PageRichard... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:HafleyGail... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:LeeKerry LKL | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:FisherJohn... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:JosephsonMark... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:BuxtonAlfred... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:ZimetbaumPete... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:O'TooleMichae... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:ReynoldsMatth... | lld:pubmed |
| pubmed-article:15289365 | pubmed:author | pubmed-author:BatsfordWilli... | lld:pubmed |
| pubmed-article:15289365 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15289365 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:15289365 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:15289365 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15289365 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15289365 | pubmed:pagination | 766-9 | lld:pubmed |
| pubmed-article:15289365 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:meshHeading | pubmed-meshheading:15289365... | lld:pubmed |
| pubmed-article:15289365 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15289365 | pubmed:articleTitle | Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. | lld:pubmed |
| pubmed-article:15289365 | pubmed:affiliation | Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Boston, Mass 02215, USA. pzimetba@BIDMC.harvard.edu | lld:pubmed |
| pubmed-article:15289365 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15289365 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15289365 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15289365 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289365 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289365 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15289365 | lld:pubmed |
